Skip to content

    Adaptive Biotechnologies (ADPT) stock price & financials

    View ADPT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+94.2% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $46.44M
    $47.46M
    $52.44M
    $58.88M
    $93.97M
    +102.4%
    $71.68M
    +51.0%
    $70.87M
    +35.1%
    $71.55M
    +21.5%
    Strengthening
    Operating Profit
    -$32.63M
    -$33.84M
    -$29.60M
    -$25.04M
    $10.29M
    -$12.77M
    +62.3%
    -$19.21M
    +35.1%
    -$15.77M
    +37.0%
    Strengthening
    Net Profit
    -$32.07M
    -$33.69M
    -$29.85M
    -$25.61M
    $9.55M
    -$13.58M
    +59.7%
    -$20.03M
    +32.9%
    -$39.79M
    -55.3%
    Strengthening
    EPS
    $-0.22
    $-0.20
    $-0.17
    $0.06
    $-0.13
    +35.0%
    $-0.25
    -47.1%
    Weakening
    Other Income
    Interest
    $2.94M
    $2.95M
    $2.90M
    $2.95M
    $2.97M
    +1.1%
    $2.95M
    +0.1%
    $2.89M
    -0.6%
    $2.69M
    -8.6%
    Weakening
    Depreciation
    Profit before Tax
    MarginsOPM
    -70.3%
    -71.3%
    -56.5%
    -42.5%
    10.9%
    -17.8%
    +75.0%
    -27.1%
    +52.0%
    -22.0%
    +48.2%
    Strengthening
    Tax
    ReturnsROIC
    2.3%
    2.4%
    2.1%
    1.8%
    -0.7%
    -129.8%
    1.0%
    -59.7%
    1.4%
    -32.9%
    2.8%
    +55.3%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$55.03M$96.58M$123.44M$139.06M$90.03M$65.06M$47.92M$70.50M$169.87M
    Short-Term Investments
    Total Current Assets$180.72M$612.69M$726.91M$402.75M$562.15M$410.19M$283.75M$300.19M$420.56M
    Net PP&E$19.13M$60.35M$139.04M$172.94M$164.21M$120.32M$94.38M$74.72M$68.57M
    Goodwill$118.97M$118.97M$118.97M$118.97M$118.97M$118.97M$118.97M$118.97M$118.97M
    Intangibles$13.63M$11.93M$10.22M$8.53M$6.83M$5.13M$3.42M$1.73M$884.0K
    Total Assets$332.69M$912.30M$1.12B$923.34M$856.62M$661.13M$539.38M$512.74M$640.68M
    LiabilitiesTotal Current Liabilities$22.80M$78.31M$105.20M$113.81M$109.79M$88.02M$98.05M$89.92M$87.71M
    Short-Term Debt$865.0K$4.64M$0
    Long-Term Debt$125.36M$130.66M$132.41M$126.57M$0
    Long-Term Leases$104.33M$106.69M$98.77M$89.39M$79.15M$70.23M$66.80M
    Total Liabilities$29.94M$341.26M$373.15M$319.24M$392.52M$352.86M$336.89M$287.74M$490.02M
    EquityCommon Stock & APIC$1.0K$12.0K$14.0K$14.0K$14.0K$14.0K$14.0K$15.0K$16.0K
    Retained Earnings-$295.91M-$365.48M-$511.61M-$718.89M-$919.08M-$1.14B-$1.30B-$1.36B-$1.42B
    Total Equity-$258.11M$571.04M$743.27M$603.99M$464.17M$308.40M$202.71M$218.79M$142.91M
    HighlightsNet Cash / (Debt)-$85.36M-$60.71M$169.87M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$32.26M$205.40M-$149.68M-$192.73M-$183.94M-$156.32M-$95.21M-$45.99M-$21.01M
    Cash from Investing$736.0K-$481.70M-$117.04M$181.21M$2.90M$129.65M$77.79M$37.95M-$25.30M
    Cash from Financing$1.25M$319.92M$293.59M$27.15M$132.26M$2.25M$241.0K$30.40M$173.03M
    SummaryCapital Expenditure-$6.30M-$11.20M-$18.80M-$61.75M-$16.35M-$10.70M-$3.66M-$2.96M-$3.02M
    Free Cash Flow-$38.56M$194.20M-$168.49M-$254.47M-$200.29M-$167.02M-$98.88M-$48.95M-$24.03M
    FCF Margin-69.3%228.3%-171.3%-164.9%-108.1%-98.1%-55.3%-17.7%-7.8%

    Ratios